Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Patching-Atropine for Residual Amblyopia
NCT00506675Phase 3Terminated
- Sponsor
- Jaeb Center for Health Research
- Start
- Oct 2007
- Primary completion
- Apr 2009
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atropine in amblyopia, sponsored by Jaeb Center for Health Research. Started Oct 2007; status: terminated.
02
Drugs
atropine
03
Conditions
amblyopia
Beyond the preview
Go deeper on NCT00506675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00506675.